| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/20/2007 | EP1796466A2 Antibacterial agents |
| 06/20/2007 | EP1796463A2 Topical endoparasiticide and ectoparasiticide formulations |
| 06/20/2007 | EP1796460A2 Use of methyl pyruvate or methyl pyruvic acid for the treatment of diseases of the nervous system and for protecting a human central nervous system against neuronal degeneration caused by defective intracellular energy production |
| 06/20/2007 | EP1696935B8 Novel derivatives of morphine-6-glucuronide, pharmaceutical compositions containing said derivatives, preparation method thereof and uses of same |
| 06/20/2007 | EP1663966B1 1,3-disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases |
| 06/20/2007 | EP1663186B1 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound |
| 06/20/2007 | EP1648892B1 Aryl-substituted benzo[d]isothiazol-3-ylamine analogues as capsaicin receptor modulators |
| 06/20/2007 | EP1611094B1 Pyrazole compounds |
| 06/20/2007 | EP1610786B1 4-(4-(heterocyclylalkoxy phenyl)-1-(heterocyclyl-carbonyl)piperidine derivatives and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer's |
| 06/20/2007 | EP1599452B1 3-(2-phenyl-oxazol-4-yl methoxy) cyclohexylmethoxy acetic acid derivatives and related compounds used as ppar modulators for treating type 2 diabetes and arteriosclerosis |
| 06/20/2007 | EP1534256A4 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/20/2007 | EP1517687B1 Medicament for the treatment of the systemic inflammatory response syndrome |
| 06/20/2007 | EP1487824B1 Diamino-pyrimidines and their use as angiogenesis inhibitors |
| 06/20/2007 | EP1472351B1 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 06/20/2007 | EP1471921A4 Counteracting bioprosthetic calcification |
| 06/20/2007 | EP1455770B1 Use of norepinephrine reuptake inhibitors for the treatment of tic disorders |
| 06/20/2007 | EP1414457B1 Chiral dinapsoline |
| 06/20/2007 | EP1413308B1 Hypoglycemic agent |
| 06/20/2007 | EP1406946B1 Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug |
| 06/20/2007 | EP1383762B1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 06/20/2007 | EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/20/2007 | EP1379254B1 Use of bile acid or bile salt fatty acid conjugates |
| 06/20/2007 | EP1373253B1 Inhibitors of cyclin dependent kinases as anti-cancer agent |
| 06/20/2007 | EP1368022B1 Use of a vial containing an oxaliplatinum solution |
| 06/20/2007 | EP1324760B1 Creatine ester pronutrient compounds and formulations |
| 06/20/2007 | EP1281083B1 Methods for detecting inflammation and inflammatory conditions |
| 06/20/2007 | EP1274840B1 Ligand for herpes simplex virus entry mediator and methods of use |
| 06/20/2007 | EP1180520B1 Pyrimidine carboxylic acid derivatives |
| 06/20/2007 | EP1158989B1 Use of inhibitors of endotoxin for the treatment of cachexia |
| 06/20/2007 | EP1137439B1 Stabilization of rapamycins or derivatives of rapamycins |
| 06/20/2007 | EP1105408B1 Congugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 06/20/2007 | EP0973791B1 Process for the preparation of an epoxy compound |
| 06/20/2007 | EP0789593B1 Yeast-based delivery vehicles |
| 06/20/2007 | EP0745121B1 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 06/20/2007 | EP0716596B1 New pharmaceutical compositions for topical use containing hyaluronic acid and its derivatives |
| 06/20/2007 | CN1985169A Use of TWEAK modulators and inhibitors for the treatment of neurological conditions |
| 06/20/2007 | CN1984999A Tolerance-induced targeted antibody production |
| 06/20/2007 | CN1984990A Improved prebiotic |
| 06/20/2007 | CN1984918A Ketolide antibacterials |
| 06/20/2007 | CN1984917A HIV integrase inhibitors: cyclic pyrimidinone compounds |
| 06/20/2007 | CN1984916A Thienopyridine derivatives, production method and use thereof |
| 06/20/2007 | CN1984914A Amide derivatives of 7-amino-3-phenyl-dihydropyrimido [4,5-d]pyrimidinones, their manufacture and use as protein kinase ingibitor |
| 06/20/2007 | CN1984912A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 06/20/2007 | CN1984911A 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha7-NACHR ligands for the treatment of CNS diseases |
| 06/20/2007 | CN1984910A Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitabale for the treatment of neurodegenerative disorders |
| 06/20/2007 | CN1984909A Thiazolinone unsubstituted quinolines |
| 06/20/2007 | CN1984908A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 06/20/2007 | CN1984907A Novel heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 06/20/2007 | CN1984906A Condensed benzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR1) activity |
| 06/20/2007 | CN1984905A Constrained himbacine analogs as thrombin receptor antagonists |
| 06/20/2007 | CN1984904A 3-aryl-5,6-disubstituted pyridazines |
| 06/20/2007 | CN1984903A 1 (indole-6-carbonyl-D-phenylglycinyl) -4- (1-methylpiperidin-4-yl) piperazine D-tartrate |
| 06/20/2007 | CN1984901A Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors. |
| 06/20/2007 | CN1984900A Indole derivatives having piperidine rings |
| 06/20/2007 | CN1984899A CXCR1 and CXCR2 chemokine antagonists |
| 06/20/2007 | CN1984892A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 06/20/2007 | CN1984888A Substituted azetidine compounds, their preparation and use as medicaments |
| 06/20/2007 | CN1984887A Method of evaluating evenness of suplatast tosilate crystal, even crystal, and process for producing the same |
| 06/20/2007 | CN1984885A Bicyclic aromatic sulfinyl derivatives |
| 06/20/2007 | CN1984883A Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies |
| 06/20/2007 | CN1984879A Carboxamido opioid compounds |
| 06/20/2007 | CN1984876A Diamine beta2 adrenergic receptor agonists |
| 06/20/2007 | CN1984694A Combination of radio waves and pharmacologically active substances |
| 06/20/2007 | CN1984682A Solid medicinal preparation |
| 06/20/2007 | CN1984681A Agent for promoting the recovery from dysfunction after the onset of central neurological disease |
| 06/20/2007 | CN1984666A Parapoxviruses in combination with other antiviral agents for the treatment of HIV/AIDS |
| 06/20/2007 | CN1984664A Methods for treating bleeding disorders using sulfated polysaccharides |
| 06/20/2007 | CN1984663A Effective treatment of tumors and cancer with triciribine and related compounds |
| 06/20/2007 | CN1984662A Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/20/2007 | CN1984661A Controlled-release formulations containing vardenafil |
| 06/20/2007 | CN1984660A 4-arylamino-quinazolines as activators of aspartic acid specificity cysteine protease and inducers of apoptosis |
| 06/20/2007 | CN1984659A Opioids for the treatment of the restlessness of the lower limbs |
| 06/20/2007 | CN1984658A Opioids for the treatment of the chronic obstructive pulmonary disease (COPD) |
| 06/20/2007 | CN1984657A Using method and compositions comprising immunomodulatory compounds for treatment and management of myeloproliferative diseases |
| 06/20/2007 | CN1984656A Cancer treatment method |
| 06/20/2007 | CN1984655A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 06/20/2007 | CN1984654A Combination of anti-HIV reverse transcriptase and protease inhibitors |
| 06/20/2007 | CN1984653A Combinations of inhibin with bronchodilators |
| 06/20/2007 | CN1984652A Using methods and compositions comprising selective cytokine inhibitory drugs for treatment and management of myeloproliferative diseases |
| 06/20/2007 | CN1984651A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 06/20/2007 | CN1984650A Hair growth promoting agents |
| 06/20/2007 | CN1984649A Fat combustion accelerator |
| 06/20/2007 | CN1984648A Botanical extract compositions and methods of use |
| 06/20/2007 | CN1984647A Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis |
| 06/20/2007 | CN1984646A Use of phenylethanolaminotetralines for preparing anxiolytic drugs |
| 06/20/2007 | CN1984645A Memantine as adjunctive treatment to atypical antipsychotic in schizophrenia patients |
| 06/20/2007 | CN1984644A Stabilised supersaturated solid solutions of steroidal drugs |
| 06/20/2007 | CN1984643A Method and composition for treating rhinitis |
| 06/20/2007 | CN1984642A Aerosol suspension formulations containing TG 227 ea or TG 134 a as a propellant |
| 06/20/2007 | CN1984641A Pharmaceutical composition of piperazine derivatives |
| 06/20/2007 | CN1984638A Powder formulations for inhalation, comprising enantiomerically pure beta-agonists |
| 06/20/2007 | CN1982327A Phytosterin compound and its use |
| 06/20/2007 | CN1982324A Oncogene, recombinant protein derived therefrom, and uses thereof |
| 06/20/2007 | CN1982316A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 06/20/2007 | CN1982313A Camptothecin compound containing multiple organic hydroxy-acid group on 10-bit substituent, its production and composition |
| 06/20/2007 | CN1982308A Substituted pyrazoles |
| 06/20/2007 | CN1982306A Alpha-substituted-2-methyl-5-nitro-diazole-1-alcohol derivative with optical activity |
| 06/20/2007 | CN1982299A Benzoxasine and benzothiasine derivatives and pharmaceutical composition containing the same |
| 06/20/2007 | CN1982298A Hydro diamine compound, its production and use and composition containing it |
| 06/20/2007 | CN1981872A Use of PUMA in tumor chemoradiotherapy sensibilization |